We are live on ! Find out more

Micro Cap Biotechnology
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
TCRX icon
176
TScan Therapeutics
TCRX
$18.8M
$18.8M $0.2769 0.54%
PBM icon
177
Psyence Biomedical
PBM
$18.6M
$18.6M $4.88 2.79%
NEUP
178
Neuphoria Therapeutics
NEUP
$18.5M
$18.5M $3.42 0.87%
DYAI icon
179
Dyadic International
DYAI
$18.3M
$18.3M $0.4565 0.71%
ESLA icon
180
Estrella Immunopharma
ESLA
$18.2M
$18.2M $0.4193 2.26%
LPCN icon
181
Lipocine
LPCN
$18.1M
$18.1M $2.20 4.76%
NCEL
182
NewcelX Ltd
NCEL
$17.6M
$17.6M $3.04 2.7%
ACTU
183
Actuate Therapeutics
ACTU
$17.4M
$17.4M $0.7242 10.8%
MRKR icon
184
Marker Therapeutics
MRKR
$17.3M
$17.3M $1.04 2.97%
PTN
185
Palatin Technologies
PTN
$17M
$17M $9.52 1.17%
RADX
186
Radiopharm Theranostics
RADX
$16.8M
$16.8M $1.15 2.54%
BCDA icon
187
BioCardia
BCDA
$16.5M
$16.5M $1.09 2.83%
ALLR
188
Allarity Therapeutics
ALLR
$15.7M
$15.7M $0.9840 0.13%
DARE icon
189
Dare Bioscience
DARE
$15.5M
$15.5M $0.7900 5.17%
KTTA icon
190
Pasithea Therapeutics
KTTA
$14.8M
$14.8M $0.4434 0.81%
TVRD
191
Tvardi Therapeutics
TVRD
$14.7M
$14.7M $1.10 1.85%
KPTI icon
192
Karyopharm Therapeutics
KPTI
$14.6M
$14.6M $0.6450 0.75%
HIND
193
Vyome Holdings
HIND
$14.3M
$14.3M $2.04 0.97%
CLRB icon
194
Cellectar Biosciences
CLRB
$14.3M
$14.3M $1.51 0%
INAB icon
195
IN8bio
INAB
$13.8M
$13.8M $1.40 0.72%
CTXR icon
196
Citius Pharmaceuticals
CTXR
$13.8M
$13.8M $0.5011 4.24%
LTRN icon
197
Lantern Pharma
LTRN
$13.6M
$13.6M $0.9100 4.58%
TPST icon
198
Tempest Therapeutics
TPST
$13.4M
$13.4M $0.7914 0.5%
PLUR icon
199
Pluri
PLUR
$12.8M
$12.8M $1.04 5.05%
LSTA icon
200
Lisata Therapeutics
LSTA
$12.6M
$12.6M $1.17 3.31%
6 7
8
9 10

Micro Cap Biotechnology Stocks at a Glance

Biotechnology companies research and develop novel drugs and therapies, often with no products yet on the market. Clinical-trial readouts and regulatory decisions drive binary stock moves, making pipeline breadth, cash runway, and partnership deals the key variables.

There are 288 micro cap Biotechnology stocks — companies in the Biotechnology industry with a market cap under $250M — worth a combined $20.1B.

The largest by market cap are Immuneering (IMRX) at $250M, Nautilus Biotechnolgy (NAUT) at $249M and Vicore Pharma Holding AB ADS (VCRE) at $244M.

Among institutional investors, Eledon Pharmaceuticals (ELDN) drew the most net new fund positions in Q2 2026: 51 funds opened new positions, taking total fund holders up 40 (33%) quarter-over-quarter.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.